Sodium Starch Glycolate (SSG) Market Poised for Steady Growth in the Future
Sodium Starch Glycolate (SSG) can be obtained by carboxy methylating starch from various origins. Market Research Future (MRFR) has published a research report about the global sodium starch glycolate market that predicts growth for this market during the forecast period between 2020 and 2027.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5763
Key Players
The key players in the
global sodium starch glycolate market include DFE Pharma (Germany), H.P.
Chemicals (India), JRS Pharma (Germany), Muby Chemicals (India), NB
Entrepreneurs (India), Prachin Chemical (India), Remedy labs (India), Roquette
(French), Shree Chemicals (India), and Spectrum Chemical Manufacturing Corp.
(USA).
The major reason for the
growth of the global sodium starch glycolate market is the
use of sodium carboxymethyl starch in
sodium carboxymethyl cellulose due to cost-effectiveness.
Another important factor leading to market growth is increasing the number of non-communicable diseases and chronic
respiratory diseases due to the changing habits and aging population because of
which the demand for sodium starch glycolate is increasing. In the
pharmaceutical industry, the SSG use is increasing due to rising health
awareness and longer life expectancies among consumers across the globe.
Therefore, the market is increasing.
The global sodium starch
glycolate market has been segmented on the basis of application,
product, and lastly, region. The application-based
segmentation segments this market into adhesives, food ingredients, pharmaceuticals,
textile, and others. SSG is used as an additive in glues for plywood. The
growing use of paper bags due to durability and eco-friendliness is fueling the
demand for adhesives. Based on the product, the market has been segmented into corn,
potato, wheat, and others.
The regional segmentation
of the global sodium starch glycolate market segments the market into regional
markets known as North America, Latin America, Europe, Asia Pacific, and the
Middle East & Africa (MEA). North America is the dominant regional market
in the whole global market due to the presence of various drug manufacturers, the
availability of advanced medical facilities, and biotechnological pharma
companies in this region, especially in the USA. The most important factors
leading to market growth in this region include rising chronic ailments due to
changing lifestyle and hectic work schedule and the rising demand for the
product in the pharmaceutical industry. The market in here is also growing to
due to the presence of many key market players and a high level of research and
development (R&D). Demand for adhesives is also contributing to the market
growth due to the revival of the automotive industry in North America and the
prevalence of a large number of automotive manufacturers. After the USA, Canada
is the most important country-specific market.
Argentina and Brazil are
two strong economies that have the potential to grow as suitable markets in
Latin America. Latin America is an important market but smaller compared to
North America as it lacks in the standard of technological advancement and
advanced medical facilities, compared to North America.
Europe is another
substantial regional market due to the extensive R&D activities happening
in this region. Government initiatives regarding R&D are the main reason
that boosts the market in Europe. Healthcare spending in Germany is more than the
US $ 400 bn of which 14% accounted for pharmaceutical products. That makes
Germany, the most important country-specific market. Other crucial
country-specific markets in this region are France, Italy, Poland, Russia,
Spain, and the UK.
Access
Report Details @ https://www.marketresearchfuture.com/reports/zinc-dialkyldithiophosphates-additive-market-5763
The Asia Pacific is the
third most important regional market that is largely driven by the rapid growth
of the Indian pharmaceutical industry. Factors boosting the market growth in
this region are growing per capita income and rising health awareness among the
consumers. Vital country-specific markets in this region are Austalia, China,
Japan, and New Zealand, followed by the remaining countries in the Asia Pacific
region.
In the MEA region, the market
is limited due to poor countries, lack of awareness, lack of technological
advancements, lack of advanced medical facilities, low standard of medical
facilities, lack of education, lack of healthcare facilities, and most
governments not considering healthcare a priority. In this region, the
significant country-specific markets are Israel, Kuwait, North Africa, Oman,
Qatar, Saudi Arabia, Turkey, and the United Arab Emirates (UAE), followed by
the remaining countries in the MEA region.
Read More:
Comments
Post a Comment